SAN FRANCISCO — Vice President Joe Biden on Monday told a packed ballroom of biopharma investors and executives that after leaving the White House he plans to push their industry to make drugs affordable for patients.

“We’re going to convene a national conversation with pharmaceutical companies— many of you who are here … biotech companies and others — to ensure patients can afford treatments,” Biden said. “Too many Americans are forced to sell their homes, to go into bankruptcy, so their loved ones can get care and hope for a cure. This needs to change while still not undermining the profit motive making sure there’s a genuine reward for effort.”

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Need this corporate war brought under control right now because it is a war, there are far more casualties from this ‘maximise return to shareholders’ mentality- it is actually warlords holding governments and individuals to ransom. There is little or no relationship between drug development and price. Hep C affects 2% of the world, is curable, yet 2 million have died in 2 years because of the deliberately murderous price. I am one of those nominated to die as ‘leverage’ to force health systems and insurance companies to buy for nearly 100k what costs about 500 to make. I escaped by finding the buyers club option- generic hep C medication- which is rescuing 1000’s of people safely, and legally. Identical meds, clinical trials- I don’t work for anyone, but trying to spread the word, as this is how I survived. Please share, look up those things, or me, or fixhepc.

  • So, where was he over the past eight years as the exorbitant pricing of drugs had no limits, and was only encouraged to further increase under ACA?

    Was he paid to speak before Big Pharma?

Your daily dose of news in health and medicine

Privacy Policy